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Special Commentary
Obesity, diabetes and longevity in the Gulf: Is there a Gulf
Metabolic Syndrome? I
‘‘. . ..we do not always bear in mind, that though food may be
now superabundant, it is not so at all seasons of each recur-
ring year”
Charles Darwin (The Origin of Species)
1. Introduction
The above quote in the year of Darwin’s 200th birthday is
highly poignant as modern humans inextricably move towards a
lifestyle-induced pandemic, with rampant levels of obesity, type
2 diabetes mellitus (T2DM) and insulin resistance [1]. Unfortu-
nately, the Gulf appears to be leading the world, with T2DM rates
reaching 35% in some populations [2].
There appear to be two main causes. The ﬁrst is that humans,
like most animals, are inherently thrifty (epitomised by insulin
resistance). Life evolved in a famine and feast environment, which
has resulted in ‘thriftiness’ becoming a genetically canalised trait
resistant to mutational perturbation. However, expression of this
phenotype can be epigenetically modulated both through the in
utero environment and that of the preceding 2–3 generations [3].
The second is that this epigenetic canalisation is likely modulated
by hormetic stress factors, such as exercise, fasting, temperature
extremes and even dietary factors. These induce mild physiological
oxidative stress, which results in mitochondrial biogenesis and an
increased anti-oxidant capacity. Without these, mitochondrially-
dependent metabolic ﬂexibility can be lost, leading to a condition
currently known as the ‘metabolic syndrome’ [4]. Hormesis is well
described to extend life span in several model organisms [5]; in es-
sence, hormesis is the process where a small stress increases resis-
tance to that stress, so improving overall biological ﬁtness. The
underlying process may be represented by ‘redox-thriftiness’,
where insulin resistance is determined by the ability to resist oxi-
dative stress. Without hormetic stimulus, metabolic ﬂexibility and
resistance to oxidative stress is reduced, resulting in heightened
insulin resistance. This could potentially lead, in a calorie rich envi-
ronment, to a tipping point where physiological insulin resistance
becomes pathological due to rising oxidative stress and inﬂamma-
tion driven by ectopic fat deposition, which results in accelerated
ageing [6].
It is well established that as body mass index (BMI) increases,
so does oxidative stress, which is worsened if T2DM develops –
further reducing life expectancy [7–9]. In fact, the metabolic syn-
drome is associated with an earlier than normal onset of many
diseases of ageing, including renal disease, cancer, osteoporosis,
depression and neurodegeneration, as well as loss of sexual
function and fertility [10–15]. Of particular relevance may be
polycystic ovary syndrome (PCOS); central obesity and insulin
resistance, and thus, the metabolic syndrome may play a very
important role in its aetiology. Certainly, a better lifestyle, as well
as the insulin sensitiser, metformin, are key in its treatment [16].
There is no published data on its prevalence in the Gulf. It is there-
fore important to consider the metabolic syndrome not as an all or
nothing condition, but as a continuum with its roots very early in
life, even in utero, which can be programmed by maternal high
calorie diets [17].
It is therefore likely that T2DM is just the tip of a Gulf Metabolic
Syndrome iceberg. The metabolic syndrome is currently deﬁned as
central obesity plus two of the following factors: raised triglycer-
ides (TGs), reduced HDL, hypertension and evidence of pathologi-
cal insulin resistance, such as raised fasting plasma glucose (FPG,
now deﬁned as >5.6 mM) or previous T2DM [18]. However, the
current deﬁnitions have evolved from insulin resistance- to waist
measurement-centric, and still give widely differing prevalences
[19], suggesting that truncal fat-based deﬁnitions need to evolve
further, as there are signiﬁcant differences between ethnic groups
as well as gender [20]. For instance, current metabolic syndrome
deﬁnitions often miss slim individuals who may still be at high risk
of cardiovascular disease [21]. This indicates that more accurate
assessment of internal ectopic fat will be necessary as an early
marker of metabolic inﬂexibility, for example, by in vivo imaging.
Implicit in this is that current deﬁnitions may seriously under
estimate the true extent of this condition: it is plausible that in a
region where the population is still very young, and 1 in 2 people
are clinically obese, with over a third having diagnosed T2DM,
symptoms of the metabolic syndrome may be present in the great
majority. Clearly, the term ‘metabolic syndrome’ is not descriptive
of the condition now afﬂicting a large fraction the Gulf. We have
previously proposed that a more appropriate term might be the
‘Lifestyle-Induced Metabolic InﬂexibiliTy and accelerated AGEing’,
or, ‘LIMIT-AGE’ syndrome [6].
In this paper, we suggest that the Gulf Metabolic Syndrome
represents an extreme example of a lifestyle-induced problem
brought about by the rapidity of oil wealth-induced ‘obesogenic
urbanisation’. For instance, the society-wide introduction and
availability of labour saving devices, cheap high calorie food,
freely available water, as well as air conditioning. This has re-
sulted in the removal of nearly all positive hormetic stressors that
have, in the past, optimised biological ﬁtness of the population
and has occurred in an extremely short and epigenetically impor-
tant time frame of 2–3 generations. This may be resulting in di-
rect epigenetic transfer of metabolic inﬂexibility between
generations. Although other cultures have experienced increased
wealth, it has been over a much longer period, and critically,
has allowed society to adapt. For instance, in Brazil, obesity was
initially a problem of the higher socio-economic groups, but as
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wealth spread (indicated by increasing urbanisation and the gen-
eration of an obesogenic environment), it shifted to the poorer
socioeconomic groups, while the better off started to become
thinner again. Over a 28 year period (1975 to 2003), the overall
obesity rate in Brazil rose from about 5.0% to 11.3% [22]. Using
combined data for Saudi [23–25], linear extrapolation would sug-
gest that prevalence rate for obesity rose from less than 5% to
more than 40% over the same period. Perhaps the most startling
statistic is that obesity rates in Saudi school boys have risen from
3.4% in 1988 to 23.4% in 2005 [26]. Another example of this com-
pression of wealth distribution into a short time period might also
explain why the Hispanics in the US have a higher rate of obesity
and diabetes than the African American [7], as the latter have had
time to adapt to the US lifestyle (they have been exposed for
many generations, whereas Hispanic immigration is only 2–3 gen-
erations old). The ultimate conclusion is that within this genera-
tion, some Gulf populations may start to experience signiﬁcant
falls in absolute life expectancy, while their healthy life expec-
tancy could fall to less than 40 years. As the metabolic syndrome
is largely preventable, a return to a healthier way of living is of
paramount importance in this region – in all age groups. It may
well be less about genetics (given that all humans are thrifty),
but more about epigenetics and breaking the transmission of
stress-induced insulin resistance between generations by rein-
statement of hormesis.
2. The obesity & T2DM pandemic in the Gulf and Saudi Arabia
Prevalence rates for T2DM and CVD in sub-Saharan Africa have
seen a 10-fold increase in the last 20 years. In the Arab Gulf current
prevalence rates are between 25% and 35% for the adult popula-
tion, whilst evidence of the metabolic syndrome is emerging in
children and adolescents [2]. A recent International Diabetes Fed-
eration (IDF) summary suggests that countries in the Gulf region
have some of the highest rates of T2DM in the world (Fig. 1): this
is likely to be an underestimate.
2.1. Obesity
One of the strongest associations with T2DM is obesity, and
the resulting condition is often called ‘diabesity’. The Gulf region
not only has some of the highest rates in the world, but the rate
of increase has been dramatically faster than most other coun-
tries. Fig. 2 shows a composite of obesity prevalence data from
Kuwait, Saudi Arabia and Bahrain, compared with the global
rates, and those of USA and Brazil [22–31]. The main thing to
note is the slope of the plotted lines: prevalence rates of obesity
in Kuwait and Saudi Arabia could approach 70% by 2020. The
data also show the variability between the sexes in different
countries.
A recent study undertaken in 2006 in Saudi Arabia suggests that
only 19.9% of Saudis attending primary health care clinics had a
normal body weight: 49.9% were obese [32]. This has risen from
a rate of 35.6% in the late 1990s [33]. Worryingly, it is occurring
in a younger and younger population; in Saudi pre-school children,
it was estimated to be 10.8% in 2006 [34]. The rate in Kuwait ado-
lescents was already exceeding that of the United States in 2002
(19.9% vs 15.3%) [35,36]. Clearly a signiﬁcant number of people
in the Gulf are overweight – and getting fatter: the mean BMI in
Saudi Arabia in the late 1990s was about 29 kg/m2 [24]; using data
from 2006 [37], the mean BMI was about 30.8 kg/m2. In compari-
son, in Kuwait in 2005/6, the mean BMI was 29 kg/m2, with nearly
half of Kuwaitis having a BMI 30 kg/m2 or greater [38].
2.2. The metabolic syndrome
Although the genetics background associated with the meta-
bolic syndrome is not fully understood, a recent study found a high
prevalence of a mutation that reduced insulin secretion in Saudi
Arabia [39]. In the late 1990s, Saudi Arabia had a rate of 39.3%,
with greater rates found in females (42 versus 37.2% for men)
and in urban, compared to rural populations (44.1 versus 35.6%,
respectively) [40]. Fig. 3 shows that the prevalence of the meta-
bolic syndrome rises rapidly with age [40–44]. As many countries
in the Gulf, such as Kuwait, have relative young societies (in the
early 1980s, nearly half the population were under 15) [45], then
it is possible that as many as 1 in 2 Kuwaitis may have deﬁnable
metabolic syndrome by 2020. As Fig. 3 suggests, it is already likely
that Saudi Arabia may have a rate of 1 in 2. Left untreated, many of
these people may well go on to develop T2DM.
2.3. Type 2 diabetes mellitus
The rising levels of obesity and the metabolic syndrome are
leading to a pandemic of diseases, in particular T2DM. However,
it is difﬁcult to precisely deﬁne and compare the prevalence, as
the rates are often measured in different age groups, as well as
in different areas – and so may not always be representative of
the population. Moreover, they are often measured over a period
of time. However, some estimates suggest that in the early part
of the new millennium the rates in the Saudi population were be-
tween 25% and 30%, 3% in the Sudan, 35% in Bahrain, 21% in Oman,
and about 17% in Kuwait [46].
One very important aspect is to ascertain the rate of increase. In
a comprehensive study in Saudi Arabia in the early 1990s, the rates
were 5.5% and 4.6% (2–70 years age group, male/female) and 9.5%
and 6.8% (14–70 years age group, male/female). Above 30 years,
these rates rose to 17.3% and 12.2%, respectively [47]. In the late
1990s in Saudi Arabia, another large scale representative study of
30–70 year olds suggested a prevalence of 23.7%, with a higher rate
in males compared to females (26.2% versus 23.7%, respectively),
and a higher prevalence in urban versus rural areas (25.5% versus
19.5%, respectively) [33]. It appears that the rate is increasing
much faster in Saudi Arabia compared to other countries, although
it is still less than Bahrain.
However, it is becoming apparent that T2DM rates are often
underestimated. The 2007 estimate of T2DM in Kuwait, suggested
a rate of 16.7%. However, the rate in 1995 was already about 14.8%
[48]. One of the emerging problems in assessing the prevalence of
T2DM is that much goes un-detected: Saadi et al. have recently
found that the original headline diabetic rate in Al Ain in the Uni-
ted Arab Emirates (UAE) was thought to be about 10%, however,
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more detailed analysis and investigation suggested an age-ad-
justed rate of nearer 29% [49].
Because of these uncertainties, we resorted to using estab-
lished odds ratios (OR) and life time risk of developing T2DM
based on BMI. In a retrospective analysis of more than 123,000
US healthcare workers, Field et al. determined the 10 year risk
of developing T2DM in different BMI categories. Within a BMI
range of 30–34.9 kg/m2, the OR for women was 10.0 and 11.2
for men, reaching 17.0 and 23.4, respectively, when over
35 kg/m2 [50]. In a more recent analysis, Narayan and colleagues
calculated the lifetime BMI-associated risk of developing T2DM
from data involving over 780,000 US subjects: lifetime T2DM
risk at 18 years of age was found to increase from 7.6% to
70.3% between underweight and very obese men and from
12.2% to 74.4% for women. This risk varied according to ethnic
background. For instance, the lifetime risk of T2DM for subjects
who are obese at 18 (BMI 30 to <35 kg/m2) is 51.8% (male) and
48.8% (female) for non-Hispanic white subjects, rising to 68.1%
(male) and 66% for Hispanics. At BMI’s of greater than 35 kg/
m2, this rises to 66.1% and 69.3%, and 81.1% and 86.0%, respec-
tively. Even at a baseline age of 45 years, with a BMI 30 to
<35 kg/m2, the ﬁgures are 47.5% and 42.2%, and 62.9% and
56.4%, respectively [7].
Using a 1995 Kuwait measured diabetic rate of 14.7%, a popu-
lation of 2 million and an obesity rate of 40%, with an estimated
normal weight diabetic rate of 1–3%, the 2005 calculated diabetic
rate could have been between 21.4% and 34.6% – an average of
28%. An 18 year old cohort from 1995 would reach 60 years of
age in 2037 and could have a diabetic rate of between 36–55%.
Applying this calculation to 2007, the diabetic rate might have
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been nearer 29% – suggesting that the current estimate of about
17% could be too low. With an obesity rate of 50% and a popula-
tion of 2.6 million, an 18 year old 2007 cohort (where the median
age was 26) would reach their 60th year in 2049: their diabetic
rate could range between 38–53%. Which ever ﬁgures are used,
it is clear that the Gulf is heading for a severe T2DM pandemic
that could reach as high as 1 in 2 people in some countries. This
data is supported by the predicted increases in obesity and met-
abolic syndrome.
3. Decreasing absolute and healthy life expectancy in the Gulf
Although average life expectancy has increased over the last
100 years to nearer 80 years in developed countries, there is clear
evidence that it may have stopped rising and may even be decreas-
ing. Moreover, it appears that the healthy life expectancy (the
amount of chronic disease free life), has not kept pace with the in-
crease in life expectancy. One likely explanation is that diseases
associated with excessive fat deposition are now being treated,
such as hyperlipidaemia and hypertension, but not cured. How-
ever, tellingly, T2DM is still on the increase. This has resulted in
many people living for many years with chronic diseases in later
life. The fundamental reason may have its roots deep in evolution
and be related to hormesis, which suggests that the cause of the
metabolic syndrome is largely environmental: both exercise and
a healthy diet reduce pathological oxidative stress and protect
against it [51,52]. One very important component is how excessive
fat is handled, and in particular, how it is stored – fat in the wrong
places can be highly inﬂammatory, but this may induce a mecha-
nism to prevent excessive weight gain. However, this mechanism
may also accelerate ageing; to help understand the relations be-
tween ectopic fat, visceral adipose tissue (VAT), insulin resistance
and accelerated ageing, we have developed the concept of ‘re-
dox-thriftiness’ [6].
3.1. Ectopic fat deposition and VAT: location, location, location
It has been suggested that a failure of fat cell proliferation,
mitochondrial function and fat oxidation results in ectopic fat stor-
age, insulin resistance and T2DM [53]. The metabolic syndrome
may therefore be caused by lipid overﬂow into normally non-adi-
potic tissues, such as the liver, muscle, pancreas and heart, and is
probably a combination of over-delivery and an inability to metab-
olise the fat that results in oxidative stress and inﬂammation [54].
Part of the problem is the chronic and continual exposure to high
levels of lipids, as although high fat feeding can initially result in
mitochondrial biogenesis in muscle and a degree of protective
compensation, this effect can be lost during chronic high fat feed-
ing [55]. However, it is not just excessive lipid within non-adipose
cells that is lipotoxic; the presence of overloaded adipocytes in or
near a particular organ can also negatively inﬂuence its function by
localised release of cytokines. For instance, fat deposited around
the heart, or even the aorta, is associated with vessel calciﬁcation
[56]. One critical set of transcription factors involved in controlling
potential lipid overload may be the PPARs. We have proposed they
could be critical in preventing lipotoxicity by ensuring safe fat
storage and burning – and thus playing a critical role in functional
longevity. Suppression of PPAR activity (e.g. by inﬂammation) may
play a critical role in a tipping point when normal physiological
insulin resistance becomes pathological due to inﬂammation (see
next section) [57].
The best recognised marker of the metabolic syndrome is
excessive VAT. However, its role in the metabolic syndrome is
still unclear: expansion of this depot may even initially have a
protective function, suggesting individual capacity thresholds
[58]. In support of this, we have proposed that the raised levels
of endocannabinoids found in the metabolic syndrome may actu-
ally be a protective mechanism – especially in the visceral region,
as they may have anti-inﬂammatory and adipogenic functions
[59]. For instance, activation of PPAR c enhances lipid trapping
in subcutaneous adipose tissue (SCAT), but appears to both en-
hance lipolysis and fat burning in VAT, as well as inducing mito-
chondrial biogenesis in both tissues [60]. However, VAT may
contain a higher density of mitochondria than SCAT, and has a
higher oxidative capacity [61]. Hence, the ﬁnding that VAT exhib-
its a greater degree post-prandial thermogenesis, compared to
SCAT, does suggest it is metabolically much more active [62].
We have therefore suggested that VAT could play an important
role in preventing excessive fat deposition – this may be partly
driven by inﬂammation [6].
In summary, mitochondrial dysfunction is an important cause
of metabolic inﬂexibility and the metabolic syndrome [4]; it is thus
likely that this inﬂexibility extends beyond muscle to just about
every tissue – including adipose tissue. Within this paradigm, the
expansion of VAT may be an inﬂammatory-driven short-term
anti-lipotoxic mechanism – where the inﬂammation is derived
from ectopic fat deposition. Thus, where the excess fat is deposited
is critical.
3.2. Redox-thriftiness and hormetic stimuli
Thriftiness arose from an evolutionarily-driven need to mini-
mise energy expenditure, which might reduce mitochondrial den-
sity [63]. However, this has to be balanced with the need to resist
the oxidative stress associated with redox signalling and pathogen
resistance. Redox signalling is a fundamental signalling mecha-
nism [64,65] and the mitochondrion is critical [66]. This may have
given rise to something we have called ‘redox-thriftiness’ [6]. In es-
sence, mitochondria may be able to both amplify membrane-de-
rived redox growth signals, but then negatively regulate them in
concert with increased anti-oxidative stress systems, resulting in
an increased ATP/ROS ratio. This means that the ability to resist
oxidative stress may determine insulin resistance, as insulin sig-
nalling involves redox. In this paradigm we suggest that insulin
initially induces mild oxidative stress (via membrane ROS, which
is then ampliﬁed by the mitochondrion). The increased oxidative
stress then suppresses the insulin signalling pathway (classic neg-
ative feedback). Hence, redox-thriftiness initially leads to physio-
logical insulin resistance, which has the effect of both protecting
the individual cell from excessive growth/inﬂammatory stress,
while ensuring energy is channelled to the brain, the immune sys-
tem, and for storage. However, the increased oxidative stress
might act as a mild mitochondrial biogenic signal. The resultant
improvement in mitochondrial function then reduces mitochon-
drial redox ampliﬁcation of the insulin signal, maintaining insulin
sensitivity. It is thus possible that optimum modulation of redox-
thriftiness requires more than one ‘mitohormetic’ signal, for in-
stance, concurrent insulin and environmental hormetic signals
that stimulate mitochondrial biogenesis and resistance to oxida-
tive stress.
This suggests that without enough hormetic stimuli, insulin
resistance would increase – this was probably never the case in
our ancestor’s time. Indeed, life probably evolved in a ‘hormetic
zone’ where a degree of stress results in optimal ﬁtness [67]. ‘Mito-
hormetic’ stimuli that result in mitochondrial biogenesis, such as
some plant polyphenols, cold, exercise and fasting, are protective
and result in improved functional longevity [68]. The tipping point
may well be determined by a combination of epigenetic factors
and hormetic tone [59]. It is very likely that most individuals can
become more thrifty, especially if they, or their immediate ances-
tors were exposed to famine – a thrifty ‘epigenotype’ [3]. A loss of
hormetic tone, which is normally generated by physical activity,
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fasting, temperature extremes, dehydration, or even dietary com-
ponents (e.g. resveratrol), may result in a reduced ability to deal
with excessive calories.
3.3. The tipping point, VAT and longevity
At the present time, deﬁnitions of the metabolic syndrome re-
volve around truncal fat and do not discriminate between inter-
nal and external abdominal fat, or other sites of ectopic fat
deposition, such as the liver. However, it is clear that increased
VAT is a major marker of risk, and does inﬂuence the pathology;
recent data suggest that removal of VAT can increase life expec-
tancy [69]. We have proposed that increasing visceral and ectopic
fat drives a mild inﬂammatory response that may have two evo-
lutionary functions: to prevent excessive weight gain, and to im-
prove population turnover by shortening life expectancy (so is
opposite to the longevity induced by calorie restriction) [6].
Fig. 4 summarises the tipping point and the role of hormesis
(e.g. physical activity), and VAT, in determining healthy life
expectancy. In essence, without hormetic stimuli, metabolic ﬂex-
ibility and the ability to resist a high intake of calories decreases.
In a high calorie environment without hormesis, fat is not stored
as efﬁciently, resulting in spill over into other organs, resulting in
inﬂammation. One of the emergency stores could be VAT, which
as it ﬁlls up, both attempts to burn off excessive energy while
releasing an inﬂammatory anorexic signal, which increases insu-
lin resistance. This results in what might be described as patho-
logical insulin resistance, which is in fact a mechanism to
prevent excessive weight gain. The downside, at least for the
individual, is a rise in life shortening systemic oxidative stress.
However, a powerful hormetic stimulus increases metabolic ﬂex-
ibility, which breaks the cycle, and enables the system to deal
with more calories – even if it means storing excess energy.
3.4. Modern life expectancy
Average life expectancy from birth has increased steadily in the
last 1000 years, and between 1900–1990 in developed countries, it
rose from between 33–53 years (Portugal/Australia) to between
68–76 years (Poland/Japan) for men, and between 35–55 years
(Portugal/Denmark) to 75–82 years (Hungary/Japan) for women
[70]. The underlying improvements came from better hygiene
and anti-pathogenic treatments, as well as better nutrition. The
cause of death therefore shifted from infectious/parasitic diseases
to chronic diseases related to ‘ageing’. This then led to a great deal
of excitement that the upper limit would continue to increase, ris-
ing to an average life expectancy of nearer 100 years by 2060 [71].
In fact, recent projections, based on cumulative damage to vascular
elastin, suggest that the real upper limit may be nearer to 120
years [72].
Data now show that the projected increase in life expectancy
in some countries, like the USA, has now reached a plateau and
may even be falling. In the late 1990s, a female in the USA could
expect to have another 18–20 years of life at age 65: in the
coming decades, because of obesity, this could fall by several
years [71]. This situation has been confused despite the fact that
the average BMI and rate of obesity has risen rapidly (in the 25
years, obesity rates in adults have risen from 13% to 31% in the
USA), because there has been a profound reduction in common
cardiovascular risk factors due to drug treatments for hypercho-
lesterolaemia and hypertension, as well as a reduction in smok-
ing. However, T2DM has increased. The net result is a population
that is, paradoxically, more obese, diabetic, arthritic, disabled,
and medicated, but with lower overall CVD risk [29]. In short,
despite lifestyle-induced chronic disease, people are surviving
longer because of better healthcare – but are doing so with
many co-morbidities.
This has led to the concept of healthy or successful aging and
healthy life expectancy, as opposed to outright life expectancy. It
is also called health-adjusted life expectancy (HALE). In essence,
it is the period people can expect to live without poor health. In
2002, an African male could expect 40 years, while females in
developed countries could expect 70 years [73]. Analysis of US
data up to the 1990s by Robine and Ritchie [74] suggested that
the increase in life expectancy was not matched by increased
healthy life expectancy. In terms of mortality, the main culprits
were disorders of the circulatory system, malignant neoplasms
and accidents. In contrast, for morbidity, the ranking is still dis-
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orders of the circulatory system, but then locomotor disorders
and then respiratory disorders. In 1980, the life expectancy of
the average man in the USA was about 79 years, but would ex-
pect to experience disability for the last seven years. For women,
these ﬁgures were 83, and nine years, respectively. Using data in
this paper, if the top four diseases were signiﬁcantly reduced, an
extra 11.6 years (average for both sexes) of disability free life
could be added, plus another 6.5 years of life expectancy – a to-
tal of about 18.3 years. Thus, life expectancy could be increased
to nearer 95–98 years, with only potentially 6–8 years of low-le-
vel disability at the end of life. Others have concluded that in
the modern (developed) world, a long life is not necessarily a
healthy one [75].
In summary, although the average life expectancy for most
people in the developed world is about 80 years, they are expe-
riencing increased morbidity and reduced quality of life in later
years. If only circulatory diseases could be reduced, then an ex-
tra 4.2 years of disease free life could be expected, with an-
other 4.1 years of life expectancy – a gain of 8.3 years [74].
Critically, many of the factors that lead to circulatory disease
are modiﬁable and thus largely preventable to some degree.
The best way to do this is via a proper lifestyle, involving both
good nutrition and a reasonable level of physical activity
[76,77].
3.5. Healthy and absolute life expectancy in the Gulf
The preceding discussion suggests a spiralling level of morbid-
ity in the Gulf. BMI-related risk can start to increase at 25 kg/m2 or
even less. For instance, risk of CHD can rise by 8% per BMI point
[78], while a BMI of 40 kg/m2 or more is associated with a 52%
greater chance of dying for cancer for men, and 62% for women
[79]. Data show that if someone maintains a BMI of about 35
throughout their life (from 20 years of age), then they can expect
to live 2–4 years less than average, falling by 4–6 years as their
BMI reaches 40 kg/m2 [80]. However, other estimates suggest that
being obese at the age of 40 reduces lifespan by as much as seven
years, while even having a BMI of 25 kg/m2 may reduce it by two
[81]. However, these effects on life expectancy are drastically mod-
iﬁed by T2DM [7]. In contrast, it is possible to be overweight, but ﬁt
and insulin sensitive without the metabolic syndrome; this pheno-
type could be represented by a swimmer, a body builder or even a
Sumo wrestler. It is thus vital to understand that the negative con-
notations of an above average BMI must be taken in the context of
the person’s lifestyle.
The risk of T2DM is on par with the risk associated with mod-
erate smoking, with one estimate suggesting it reduces life expec-
tancy by as much as 10 years [81]. It has been calculated that in
the year 2000, in individuals with T2DM younger than 35 years,
75% of all deaths were attributable to T2DM. In individuals with
T2DM aged 35–64 years, 59% of deaths were attributable to
T2DM; while individuals with T2DM and older than 64 years,
29% of all deaths were attributable to T2DM [82]. Narayan and
colleagues calculated that if someone had a BMI of 30–35 kg/m2
at age 18 years, developing T2DM could reduce life expectancy
by as much as 10–12 years. Life expectancy could fall by as much
as 15 or so years if the BMI was greater than 35 kg/m2. As ex-
pected, the effect on life expectancy reduced with advancing
age of onset [7]. Interestingly, if these overweight subjects did
not develop T2DM, they could expect a relatively normal lifespan
[7] – which reinforces the importance of T2DM as a major risk
factor.
The very high rates of obesity and emerging T2DM in the Gulf
could have a serious impact on life expectancy. Using the above
data, with a median age of 26 in 2007, an obesity rate of 50%,
a metabolic syndrome rate approaching 40%, and possibly, a dia-
betic rate approaching 30%, then at least 30–40% of those alive in
2007 may have their life expectancy reduced from approximately
76–79 to 64–67 years. However, if the obesity rates continue to
rise at the predicted rate (and the population still retain a non-
hormetic lifestyle), resulting in an expansion of the cohort with
a BMI of greater than 35 kg/m2, then a percentage (as much
10%), may see their life expectancy reduced to less than 60 years
of age, with a healthy life expectancy of not much more than 40
years. This may be 30–40 years less than what may be
achievable.
4. Why the Gulf Metabolic Syndrome is so severe
The main reason is likely due to a rapid removal of hormetic
stimuli in a very short time period, and the sudden presence of
unlimited calories. Countries who have had their wealth the lon-
gest, such as Saudi Arabia, could be worst affected. Furthermore,
this change has happened within epigenetic memory of harder
times (i.e., a few generations). The result is that a thrifty epigeno-
type adapted to a harder environment, but normally exposed to
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hormetic stimuli, has been plunged into an environment for which
it is not adapted. Fig. 5 summarises the problem.
4.1. Obesogenic urbanisation – shifting away from a hormetic
environment?
Arabia was originally a land of great fertility, however, over
thousands of years, it has been drying out and losing cultivable
land. The current climate is now extremely warm and dry, which
has resulted in a way of life adapted to these conditions, including
the diet and use of drought resistance and hardy animals. It is
therefore likely that the epigenotype of indigenous populations be-
came adapted to hormetic factors, such as heat stress, physical
activity (travel), periods of fasting (famine), dehydration and poly-
phenolic compounds from stress resistant plants (both directly,
and indirectly through animals, such as camels or goats). Further-
more, nearer the sea, ﬁsh would have been an important source of
protein and polyunsaturated fats.
Although human studies are scarce on the epigenetic effects of
such environments, camel’s milk does appear to be protective
against aspects of the metabolic syndrome (preventing T2DM)
[83]. Studies in rural versus urbanised Saudi children show that
the increase in asthma urban areas may well be due to adoption
of a Western diet and the loss of a the traditional Arab diet, sug-
gesting changes in the immune system [84]. Heat stress also has
a powerful hormetic effect that can extend lifespan in several
organisms [85], and recent research using mice suggests that heat
stress may also reduce insulin resistance [86]. Dehydration is also
an important stress, which stimulates anti-oxidant mechanisms in
plants, as it induces mitochondrial oxidative stress, resulting in
mechanisms to reduce ROS [87]. In mammalian cells, dehydration
induces transfer of heat shock proteins to the mitochondrion [88];
this would also suggest an adaptive response to stress. Thus, the
ﬁnding that resistance to one environmental stress, such as dehy-
dration, can improve resistance to others, such as heat shock, and
may correlate with improved longevity in fruit ﬂies [89] – is highly
suggestive that these factors may be important in the Gulf. Finally,
the concept of ‘xenohormesis’ suggests that stress molecules pro-
duced by plants (such as polyphenols), can also be interpreted by
animals and upregulate their resistance [90], may be very relevant.
It is therefore quite possible that the original harsh environ-
ment in the Gulf provided a powerful hormetic signal to the indig-
enous populations. With rapid modernisation, this signal has now
been largely removed. This has most likely been due to rapid ‘obes-
ogenic urbanisation’ across most socioeconomic groups, and the
rapid adoption of modern labour saving devices (e.g. mechanised
transport), as well as temperature control, plentiful supplies of
water and a shift to a high calorie Western diet. Furthermore,
the advent of the computer and quite possibly, a shift in leisure
time activity away from physically active pastimes for the young
has resulted in an increasingly sedentary lifestyle for youngsters
in the Gulf. It has been previously estimated that nearly 60% of
Saudi schoolchildren 70% of youth do not engage in sufﬁcient
physical activity [91]. Unfortunately, this tends to set the prece-
dent for later life; up to 96% of Saudi adults have been classed as
‘inactive’ [92].
Finally, the inﬂuence of Ramadan may also need to be consid-
ered. Alternate day fasting has been shown to mimic the longevity
inducing effects of calorie restriction in animals, and to demon-
strate some beneﬁcial alterations in biochemical markers in hu-
mans (although detailed human trials are limited at the present
time). In essence, calories are restricted on alternate days, and
may not necessarily result in a total reduced calorie input over a
number of days, but do result in enough ‘stress’ to invoke im-
proved metabolic ﬂexibility. Interestingly, the effect seems to be
more beneﬁcial in men than women, with sex differences in lipid
proﬁles (women tend to display an increase in HDL-c, whereas
men tend to show reduced triglycerides). There is also evidence
that liver triglycerides reduce, with some improvement in insulin
sensitivity [93]. However, there is very little data studying Rama-
dan and the metabolic syndrome. In one trial, healthy men did
show an improvement in insulin sensitivity during Ramadan,
which correlated with a small decreased in calorie intake [94].
While in another involving T2DM subjects, there were clear sex
differences. Although cholesterol intake increased in all (as did
LDL-c), BMI tended to reduce in men, which was correlated with
improved insulin sensitivity, but in women, BMI increased and
was not correlated with any improvements [95]. It is thus quite
likely that fasting (and dehydration), per se, is protective, but there
are likely gender differences, both physiologically and culturally.
Finally, the new ﬁeld of chronobiology does suggest that shortage
of sleep, or having large meals (especially of carbohydrate) late at
night, can disrupt the circadian rhythm and could possibly accen-
tuate the propensity to develop the metabolic syndrome. Critically,
not only does it appear that adipose tissue may well have its own
daily rhythm, but many important metabolic transcription factors,
such as the PPARs, may also follow a circadian rhythm [96]. Thus,
Ramadan could potentially be beneﬁcial (as a hormetic stressor),
but these beneﬁts may be offset (especially when it falls during
the summer with long daylight hours), by having large meals very
late in the day (which may have become more westernised), and a
reduction in sleep.
4.2. Rate of modernisation, epigenetic canalisation and Gulf hormesis
It is not just the loss of hormesis that may be important, but the
speed at which it has happened in generational terms. In the West,
the process of developing advanced civilisations that remove day-
to-day ‘stresses’, which have made life easier, has been a gradual
process over centuries and thus, 10–15 generations or more. Addi-
tionally, many of these Western cultures came from colder cli-
mates; this may confer some level of resistance to the metabolic
syndrome – the so called ‘cold genes’ hypothesis [97]. Another cul-
tural adaption has been the pursuit of physical activity to improve
body image. An example of the rate of modernisation effect may be
the observed higher rates of obesity and diabetes in the USA
amongst the immigrant Hispanic population, compared with Afri-
can American and Caucasians [7]; Hispanics migrated to the USA
fairly recently, and have therefore been exposed to ‘obesogenic
urbanisation’ within only a few generations. In contrast, African
American have been exposed to it for 10 generations or more.
In the Gulf, not only is the climate warmer, but adoption of a
western sedentary lifestyle has happened within the last 2–3 gen-
erations – and possibly even in the lifetime of some of those still
alive today. Moreover, the highly generous nature of the indige-
nous peoples in relation to food giving has continued, especially
of now readily available high calorie foods. Importantly, as the
wealth has spread to most socioeconomic classes, high calorie food
is now available to all. This has resulted in the development of a
highly obesogenic environment in a very short period, where many
grandparents may well have been exposed to times when food was
much less plentiful.
In the Gulf, not only is the climate warmer, but adoption of a
western sedentary lifestyle has happened within the last 2–3 gen-
erations – and possibly even in the lifetime of some of those still
alive today. Moreover, the highly generous nature of the indige-
nous peoples in relation to food giving has continued, especially
of now readily available high calorie foods. Importantly, as the
wealth has spread to most socioeconomic classes, high calorie food
is now available to all. This has resulted in the development of a
highly obesogenic environment in a very short period, where many
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grandparents may well have been exposed to times when food was
much less plentiful.
This may have resulted in a thrifty phenotype being exposed to
a continual supply of high calorie food, but because this phenotype
is no longer hormetically challenged, it has become metabolically
inﬂexible. This metabolic inﬂexibility is then propagated to the
next generation as the mother develops the metabolic syndrome.
One way to explain this is via the concept of ‘‘genetic canalisation”
of the thrifty trait, which is probably a characteristic of all life.
However, the expression of this trait is strongly modulated by
the environment, both immediately in the individual (e.g. during
famine), or by either exposure in utero to signals from the mother,
or possibly from previous generational exposure to famine via epi-
genetic changes [3]. In effect, because resistance to famine is such
an extremely strong survival trait, natural selection has resulted in
it becoming resistant to mutational perturbation (thus, the envi-
ronment will have a much stronger effect than individual polymor-
phisms on the expression of a particular phenotype). Without
hormesis, the epigenotype canal may become narrower and the
organism less metabolically ﬂexible. In effect, hormesis broadens
the canal, and thus, metabolic ﬂexibility enabling the epigenotype
to cope with a higher calorie intake – although it will be less en-
ergy efﬁcient. In evolutionary terms, a narrow canal meant that
the animal required fewer calories to survive, but was metaboli-
cally less ﬂexible, however, it was unlikely that the canal would
ever became too narrow, as it was always going to be exposed to
some kind of stress (e.g. the need to move, or resist temperature
extremes). Within these constraints, it was perfectly adapted.
Hence, if exposed to calories, it would be in a position to store
them.
However, the position in the Gulf is unusual. Fig. 6 depicts what
the shape and breadth of the epigenetic canal may look like be-
tween an adapted population (e.g. the UK) and a population sud-
denly exposed to a non-hormetic environment (e.g. the Gulf)
across three generations. In effect, the sudden loss of hormetic
stimuli, coupled with increased food availability, both narrows
the canal, and causes the expressed phenotype to move to the feast
side. This phenotype, as it cannot deal with continual excessive
calories, deposits ectopic fat (due to metabolic inﬂexibility) and
becomes inﬂamed. This may be part of a mechanism to resist
excessive weight gain, which induces lipolysis and activation of
the stress response. It is possible that in the short term, this stress
is itself hormetic, so widening the canal. However, if continually
exposed to ‘food stress’ without other concurrent hormetic stimuli,
the metabolic syndrome phenotype develops. This epigenotype
can then be passed onto the next generation in a similar way to
a thrifty epigenotype (e.g. by insulin resistance), however, as the
next generation may also be exposed to an obesogenic environ-
ment, it may well be even less well adapted than the previous
one. It is thus possible that with each successive Gulf generation,
the epigenotype is becoming less and less ﬂexible, with symptoms
occurring at younger and younger ages.
5. Need for early detection and invocation of lifestyle change
In the West, it is only gradually becoming accepted that preven-
tion is better than cure, as data, both clinically, and now, molecu-
larly, indicates that a healthy lifestyle greatly slows the
development of many diseases of aging. For instance, calorie
restriction, and alternate day fasting are the only proven mecha-
nisms for extending lifespan, while regular physical improves
functional longevity. One of the core mechanisms revolves around
reducing the activity of the insulin/insulin like growth factor axis,
activating certain transcription factors and improving mitochon-
drial function [77,93,98–100]. The underlying principle of horme-
sis is even less well embraced. Indeed, in countries like the UK,
the situation may be getting even worse as physical activity is sys-
tematically being reduced in schools and being replaced by a sed-
entary computer-based culture. In combination with the
emergence of the credit society (and thus, access to money for low-
er socioeconomic groups, which has generated a perception of
wealth and the ability to buy labour saving devices and high calo-
rie food), this could be generating a metabolic syndrome time
bomb. The is clearly supported by the fact that T2DM rates (in peo-
ple aged between 10–79 years) in the UK have suddenly shot up
from 2.6% in 1996, to 4.3% in 2005 [101]. This probably represents
the development of an obesogenic environment in a society that
has already adapted to wealth over many generations.
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Fig. 6. Epigenetic canalisation and transfer of ‘stress’ signal (e.g. insulin resistance) through Gulf generations due to lack of hormesis. The ball represents the current
phenotype and the canal, the epigenotype. Energy requiring hormetic factors such as exercise, temperature extremes, drought & stress polyphenols widen the canal to the
right, whereas energy reducing factors, such as famine/fasting, widen it to the left. Metabolic ﬂexibility is improved in both directions, but famine/fasting reduces energy
expenditure, while energy requiring factors increase it. Without any hormetic factors, the canal becomes so narrow that in the presence of excess food, the phenotype falls
outside and becomes permanently stressed: this is then passed on to the next generation, so perpetuating the problem.
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The answer, in part, is to invoke a societal change in lifestyle
behaviour based on early detection of the condition and to educate
on its implications with regards to absolute and healthy life expec-
tancy. The general public is unaware that T2DM is the culmination
of many years of a combination of poor lifestyle coupled to a
general human predisposition to the condition, which is already
shortening their quality of life and their life expectancy. One of
the best ways to do this may be to study fat distribution and the
presence of ectopic fat.
5.1. Early detection
Clearly, individuals who are overweight and already displaying
signs of the metabolic syndrome, especially if they are very unﬁt
and older, are easily identiﬁable: they are both fat on the outside,
and the inside (FOFI). However, the population is theGulf is still very
young. As current metabolic syndrome deﬁnitions will not pick up
early indications, there is a need for newmethods of early detection.
It needs to be remembered that these deﬁnitions are also based on
western populations and quite possibly, on population averages,
andnot necessarilywhat is actually healthy. In theUSA, themajority
of T2DM patients do not reach their treatment goals for HbA1c,
which is less than 7%, however, in reality, the risk of T2DM increases
from about 4.6%, which is about the same point that the risk of
microvascular disease also rises [102,103]. Thus, many people will
be displaying above normal HbA1c long before being diagnosed as
diabetic. In an important time period may be during childhood and
adolescence, as this is when maximum growth occurs: this may
mask the effect (as calories get used towards growing), but a corol-
lary to this is that insulin resistance may also stunt growth. Insulin
resistance, as a thrifty mechanism, encourages deposition of fat in
adipose tissue rather using it to build lean muscle tissue – ‘catch
up growth’ [104]. Hence, their may be an adolescent tipping point.
One of the strongest markers for metabolic inﬂexibility is the
presence of ectopic fat, such is in the visceral region, the liver, mus-
cle or even around the aorta [56,105,106]; thus assessing fat distri-
bution is becoming paramount. One very powerful method to
achieve this is a combination of magnetic resonance imaging and
spectroscopy. We have studied more than 1000 volunteers and
shown that fat distribution correlates very strongly with other risk
markers, such a lack of ﬁtness, dyslipidaemia, blood pressure and
markers of insulin resistance, as well as the presence of fat in
the liver [107]. We have also shown that these changes can be
measured in pre-term infants [108], and that exercise can dramat-
ically reduce visceral fat volume [109]. It is becoming increasingly
apparent that it is possible to be fat outside and thin inside (FOTI),
and thin outside and fat inside (TOFI) – with the latter being a
much riskier phenotype. Fig. 7 shows a typical MRI scan of two
people with near identical BMI, but vastly differing risk proﬁles.
5.2. The future
A number of studies are suggesting that, if left untouched, some
populations in the Gulf will have dramatically shortened life
expectancies, enduring signiﬁcant morbidity for up to a third of
their lives. This may well greatly reduce the capacity of a popula-
tion to compete in a modern world. Darwin had, over a 130 years
ago, unwittingly via the concept of natural selection, laid the seeds
for an idea that some populations could modify their environment
so successfully that their new environment would actually become
detrimental. This has been called evolutionary suicide, or Darwinian
extinction [110]. The Gulf Metabolic Syndrome could be an exam-
ple of such a process in action. In particular, conditions such as
PCOS, may well be the harbinger of this – if rates are shown to
be increasing in the Gulf, especially in young women; loss of fertil-
ity in this age group could have a serious impact on society. Fur-
thermore, in one study in Saudi Arabia, overall 86.1% of non-
insulin dependent diabetic patients had evidence of erectile dys-
function; worryingly, the rate was 25% in men aged under 50 years
[111]. With a diabetic rate approaching 1 in 3, it is possible that 1
in 4 men may already be experiencing problems.
However, this does not need to be the case. The metabolic syn-
drome is largely, if not completely, preventable and/or reversible.
Physical activity is one of the most potent preventative mecha-
nisms known, and is explainable at the molecular level. Moreover,
there are many other hormetic factors that can help to induce bio-
logical ﬁtness to survive in a modern world, ranging for plant poly-
phenols, to temperature stress, to fasting. The last of these,
epitomised by calorie restriction, is the only really reliable mecha-
nism to greatly extend lifespan and the molecular signature is ob-
servable in humans undergoing calorie restriction [112].
Unfortunately, as the propensity to develop the metabolic syn-
drome without hormesis is emerging as an inherent property for
many animals, including humans, then the Gulf has no option
but to radically change its environment to optimise the ﬁtness of
its citizens. The ﬁrst step will be to make people aware of what
is actually happening to them: this will require a very bold pro-
gramme of early screening, development of new deﬁnitions and
guidelines, and instigation of preventative lifestyle measures –
something the developed nations have not been able to do as
yet. The Gulf may have the biggest problem, but it may also, be-
cause of its culture, be the ﬁrst to be able to develop a societal-
wide paradigm to control the inexorable rise of the metabolic
syndrome.
Fig. 7. A FOTI subject versus a TOFI subject.
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6. Conclusion
Because of oil wealth, the Gulf has experienced an unprecedent-
edly rapid evolution of ‘obesogenic urbanisation’ across all socio-
economic classes. This has resulted in the loss of hormetic
factors within epigenetic memory of harder times, which has re-
sulted in the generation, and then perpetuation of metabolically
inﬂexible subsequent generations totally unable to deal with a
Western high calorie diet. This is resulting in the ‘metabolic syn-
drome’ phenotype being expressed at younger and younger ages,
which is very likely to result in a substantial reduction in both
healthy and absolute life expectancy. In effect, because thriftiness
has become a genetically canalised trait common to all animals,
benign insulin resistance has become malignant, which is associ-
ated with obesity and diabetes. This could lead to Darwinian
extinction of some populations due to accelerated ageing and early
loss of fertility. However, as this probably only goes back in two to
three generations, there is a very good chance that this could be
rapidly reversed by lifestyle modiﬁcation. Research therefore
needs to focus on the young and early detection of this condition
and reversal by reintroduction of a more ‘hormetic’ lifestyle.
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